Company
Tissium
Last checked: Nov 20, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
2
510(k), De Novo and PMA
Device trials
4
As lead sponsor, any status
Adverse event reports
2
Received Nov 1, 2025 to Nov 20, 2026
Recall records
8
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
From SEC filings.
We found no SEC financing filings under the name Tissium, so its financing is unknown here. That is common for companies based outside the US, for subsidiaries of larger companies, and for companies funded by founders, grants or customers. A company that changed its name can also be missed.
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Tissium.
Latest FDA decisions
K251957 · Decided Sep 8, 2025 · 75 days after receipt
Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD) · Neurology & Neurosurgery
- COAPTIUM Connect with TISSIUM LIGHTNew device typeDe Novo
DEN240066 · Decided Jun 17, 2025 · 208 days after receipt
Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD) · Neurology & Neurosurgery
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT06042205 · 78 participants · Start Jul 4, 2023 · Primary completion Jul 4, 2026
Device: TISSIUM™ Atraumatic Hernia Repair System (TAHRS) · For: Hernia
Sites: Genk, Belgium; Bonheiden, Belgium; Ruddershove, Belgium · 5 sites in all
- AtraUmatic Laparoscopic HerNia Repair Clinical Investigation to Evaluate the Safety and Performance of The ECLIPSIUM System for Mesh Fixation IDEPivotal-lookingRecruiting
NCT07277946 · 240 participants (planned) · Start May 14, 2026 · Primary completion Dec 2026
Device: ECLIPSIUM® System; Resorbable tacks (AbsorbaTack/SorbaFix) · For: Hernia
Sites: Loma Linda, California; Gainesville, Florida; Chicago, Illinois · 12 sites in all
- SECURE Post-Market StudyNot yet recruiting
NCT07756489 · 65 participants (planned) · Start Oct 2026 · Primary completion Apr 2028
Device: COAPTIUM® CONNECT · For: Digital Nerve Injury
1 more trials with a free account
Reports received
2
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
1
50% of reports
Injury reports
1
50% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 0 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 0 | 0 | 0 | 0 |
| Aug 24 | 0 | 0 | 0 | 0 |
| Sep 24 | 0 | 0 | 0 | 0 |
| Oct 24 | 0 | 0 | 0 | 0 |
| Nov 24 | 0 | 0 | 0 | 0 |
| Dec 24 | 0 | 0 | 0 | 0 |
| Jan 25 | 0 | 0 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 0 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 0 | 0 | 0 |
| Jun 25 | 0 | 0 | 0 | 0 |
| Jul 25 | 0 | 0 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 0 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 0 | 0 | 0 |
| Dec 25 | 0 | 0 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 1 | 0 | 0 | 0 |
| Mar 26 | 0 | 1 | 0 | 0 |
| Apr 26 | 0 | 0 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 0 | 0 | 0 | 0 |
| Jul 26 | 0 | 0 | 0 | 0 |
| Aug 26 | 0 | 0 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 0 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2901-2026 · Started Jun 15, 2026 · Posted by FDA Aug 6, 2026
Reason given: Currently labeled shelf life of 36 months is not substantiated by real-time data. Devices will be relabeled to reflect revised shelf life of 26 months. The use of a medical device beyond its validated shelf life may result in perioperative breakage of the device rendering device unusable; worst-case outcome would be...
Cause as FDA categorized it: Incorrect or no expiration date · Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD)
Z-2902-2026 · Started Jun 15, 2026 · Posted by FDA Aug 6, 2026
Reason given: Currently labeled shelf life of 36 months is not substantiated by real-time data. Devices will be relabeled to reflect revised shelf life of 26 months. The use of a medical device beyond its validated shelf life may result in perioperative breakage of the device rendering device unusable; worst-case outcome would be...
Cause as FDA categorized it: Incorrect or no expiration date · Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD)
Z-2903-2026 · Started Jun 15, 2026 · Posted by FDA Aug 6, 2026
Reason given: Currently labeled shelf life of 36 months is not substantiated by real-time data. Devices will be relabeled to reflect revised shelf life of 26 months. The use of a medical device beyond its validated shelf life may result in perioperative breakage of the device rendering device unusable; worst-case outcome would be...
Cause as FDA categorized it: Incorrect or no expiration date · Device type: In Situ Polymerizing Peripheral Nerve Repair Device (SFD)
5 more recall records with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.